|Mr. David J. Schlanger||CEO & Director||987.31k||11.91M||1959|
|Mr. Peter Anevski||Pres & COO||909.86k||5.64M||1967|
|Mr. Mark S. Livingston||Chief Financial Officer||857.01k||2.9M||1966|
|Ms. Jennifer Bealer||Exec. VP, Gen. Counsel & Sec.||499.12k||2.68M||1981|
|Mr. James Hart||VP of Investor Relations||N/A||N/A||N/A|
|Ms. Risa Fisher||Exec. VP of Marketing & Communication||N/A||N/A||N/A|
|Ms. Cassandra Pratt||Sr. VP of People||N/A||N/A||N/A|
|Mr. Michael Sturmer||Exec. VP, Chief Growth & Strategy officer||N/A||N/A||N/A|
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Progyny, Inc.’s ISS governance QualityScore as of 26 September 2021 is 7. The pillar scores are Audit: 3; Board: 6; Shareholder rights: 8; Compensation: 9.